Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

WBUR

Published October 27, 2026 at 12:01 PM EDT

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.